Burcon NutraScience Corp (TSE:BU) (NYSE:BUR) Director David Lorne John Tyrrell bought 49,100 shares of the firm’s stock in a transaction on Friday, January 12th. The shares were bought at an average cost of C$0.61 per share, with a total value of C$29,951.00.
Shares of Burcon NutraScience Corp (TSE BU) traded up C$0.03 during trading on Friday, reaching C$0.65. The company’s stock had a trading volume of 17,100 shares, compared to its average volume of 48,039. The company has a market capitalization of $26.10, a PE ratio of -4.33 and a beta of 0.30. Burcon NutraScience Corp has a 52-week low of C$0.49 and a 52-week high of C$2.50.
Burcon NutraScience (TSE:BU) (NYSE:BUR) last posted its quarterly earnings data on Friday, November 10th. The company reported C($0.03) earnings per share for the quarter. Burcon NutraScience had a negative net margin of 22,652.29% and a negative return on equity of 230.47%.
Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates.
Receive News & Ratings for Burcon NutraScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience and related companies with MarketBeat.com's FREE daily email newsletter.